AstraZeneca (NASDAQ:AZN) has announced it will shift its US listing from Nasdaq to the New York Stock Exchange, delisting its ...

U.S. President Donald Trump speaks during an announcement about lowering U.S. drug prices next to Secretary of Commerce Howard Lutnick, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr ...

London: British pharmaceutical giant AstraZeneca on Tuesday said trading of its shares on the New York Stock Exchange will start from February, in ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (AZN) today announces the launch of AstraZeneca Direct, an online platform designed to create a simple, convenient way for eligible patients to access ...

Jan 8 (Reuters) - AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the drugmaker's $50 billion investment plan in the company's ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid US leader Donald Trump's threats to impose tariffs on the sector. The funds will ...

In July, AstraZeneca announced plans to invest $50 billion by 2030 on boosting its US manufacturing and research operations - Copyright AFP Tobias SCHWARZ In July ...

A view of a helmet with the AstraZeneca logo next to a bust of former U.S. President Abraham Lincoln on the day of an announcement about lowering U.S. drug prices, at the White House in Washington, ...

British pharmaceutical giant AstraZeneca announced surging quarterly profit Thursday on strong sales of cancer drugs and as the group zones in on the United States, pressured by President Donald Trump ...

AstraZeneca's announcement included a new factory in the US state of Virginia, which will be the company's 'largest single manufacturing investment' - Copyright AFP ...

LONDON (Reuters) -AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as U.S. President Donald Trump unveiled a medicine deal that will lower drug prices for millions of ...